-
More good news from Cellmid. Patent granted in Uk for use of midkine in hair growth restoration.
Advangen in the market in Japan, China and Australia, quarterly update in a couple of weeks, Quest to get its midkine marker lung cancer test out by Oct hopefully, Full year out at end of August, possible royalties from PEB and Quest.
Interesting times ahead and at .028 looks good for .029 at least
-
Finally broken through the .030 barrier, maybe the blocking seller has finished, either that or there is another load coming.
But thats neither hair nor there.
Last edited by Minerbarejet; 24-07-2014 at 06:49 PM.
-
Revenue 2.8m, Profit/Loss -1.4m, Market Cap 20m. SP .03c Ballieu 07c - 26?c Hmmmmm, seems a bit undercooked by comparison especially with whats in the pipeline.
-
Big jump today on good volume ( 13 m so far) looked like the brakes had come off for a while.
-
 Originally Posted by Minerbarejet
Big jump today on good volume ( 13 m so far) looked like the brakes had come off for a while.
Yeah strange timing because not like there was anything new today that came out. Any idea why or just built up pressure being released. Not complaining either way, but do feel its weird timing.
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
-
Forum Rules
|
|
Reply With Quote
Bookmarks